MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study

Clinical trial NCT03403725 · TERMINATED

Trial details

NCT number

NCT03403725

Sponsor

Menarini Group

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-08-28

Primary completion

2019-10-22

Enrollment

28

View on ClinicalTrials.gov